In recent times, the Northwest Biotherapeutics (OTCMKTS NWBO) stock has been in considerable focus among investors and it is easy to see why. While it is true that there was no fresh news regarding the company this week, it should be noted that Northwest provided a major update with regards to its facility in Sawston, United Kingdom earlier this month.
The company announced that it sent in the application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for certifying its facility.
That is a major milestone for the company and naturally, it led to considerable interest in Northwest stock as well. It should be noted that the company had worked on preparing the facility for certification for around two years and a large chunk of those preparations had been conducted during the coronavirus pandemic. Considering the interest in the stock from investors, it might be a good idea to track Northwest in the coming days.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.